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Background: The purpose of this study was to determine whether seizure susceptibility due 
to antihistamines is provoked in patients with febrile seizures.
Methods: The current descriptive study was carried out from April 2009 to February 2011 
in 250 infants and children who visited the Madinah Maternity and Children’s Hospital as a 
result of febrile convulsions. They were divided into two groups according to administration 
of antihistamines at the onset of fever.
Results: Detailed clinical manifestations were compared between patients with and without 
administration of antihistamines. The time from fever detection to seizure onset was significantly 
shorter in the antihistamine group than that in the nonantihistamine group, and the duration of 
seizures was significantly longer in the antihistamine group than in the nonantihistamine group. 
No significant difference was found in time from fever detection to seizure onset or seizure 
duration between patients who received a first-generation antihistamine and those who received 
a second-generation antihistamine.
Conclusion: Due to their central nervous system effects, H1 antagonists should not be 
administered to patients with febrile seizures and epilepsy. Caution should be exercised regarding 
the use of histamine H1 antagonists in young infants, because these drugs could potentially 
disturb the anticonvulsive central histaminergic system.
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Introduction
Febrile seizures are the most common convulsive events in childhood, occurring 
in 2%–5% of children younger than 5 years of age.1 They are age-dependent and 
are uncommon before 9 months and after 5 years of age. The peak age of onset is 
approximately 14–18 months. A strong family history of febrile convulsions in siblings 
and parents suggests a genetic predisposition.2
The pathogenesis of febrile convulsions is not clear even today. Viral infections of 
the upper airways, exanthema subitum, acute otitis media, infection of the urinary tract, 
and febrile reactions after vaccination are the most frequent precipitating factors.3
It has been demonstrated that increased histamine levels elevate the seizure threshold 
and reduce the severity and duration of seizures,4 whereas decreased histamine levels 
have the opposite effect.5 Of the four histamine receptors, the histamine-1 (H1) 
and histamine-3 (H3) receptors are suggested to be of importance in decreasing 
seizure activity. The first-generation H1 receptor antagonists, such as ketotifen and 
chlorpheniramine, elicit epileptiform activity.6 The H3 receptor antagonists, which 
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block H3 autoreceptor function, are believed to decrease 
seizure activity by increasing histamine release.7
Antagonists of histamine H1 receptors are commonly 
  classified as first-generation or newer-generation anti-
histamines on the basis of their often sedating effect at 
therapeutic doses.7 The latter antihistamines, also known as 
second-generation or third-generation antihistamines, include 
astemizole, cetirizine, desloratadine, fexofenadine,   loratadine 
and terfenadine, and were developed as nonsedating 
alternatives to the first-generation compounds.
Seizures or convulsions have been reported in the literature 
with some first-generation antihistamines (chlorpheniramine, 
diphenhydramine, pheniramine, and pyribenzamine) as well as 
with some of the newer-generation antihistamines (astemizole, 
cetirizine, fexofenadine, loratadine, and terfenadine).7–9
Churchill and Gammon10 first reported that antihistamines 
such as diphenhydramine and tripelennamine activated 
epileptic discharges on electroencephalography and produced 
clinical manifestations of psychomotor seizures in adult 
epileptic patients. However, reproducibility is not high in 
patients suspected of having drug-induced febrile seizures, 
and other factors, such as fever and infection, can induce 
febrile seizures. Furthermore, the relationship between 
febrile seizures and medications has not been actively 
investigated.11,12 The aim of this study was to determine 
whether seizure susceptibility due to antihistamines is 
provoked in patients with febrile seizures.
Materials and methods
The current study was carried out from April 2009 to 
February 2011 in 283 infants and children who attended the 
Madinah Maternity and Children’s Hospital as a result of 
febrile convulsions. For the purposes of our study, the case 
definition of a febrile convulsion was a convulsive seizure 
in an infant or child in association with a fever of 38.0°C 
or higher, but without evidence of any definitive causative 
illness, such as central nervous system infection, metabolic 
abnormality, or intoxication. Thus, both simple and complex 
febrile convulsions were included. Thirty-three patients 
were excluded due to a history of afebrile seizures, cerebral 
palsy, or mental retardation. Thus, 250 patients were enrolled 
in our study. Informed consent was obtained from the 
parents of children after thorough explanation of the study. 
A specially designed and validated checklist was used by the 
attending physicians in the emergency room to record age, 
gender, family history of febrile seizures, mean maximum 
temperature, time from detection of fever to seizure onset, 
underlying disease, medications administered before seizure 
occurrence, and duration between receiving the last dose 
of antihistamine and onset of febrile seizure. The duration 
of convulsions was investigated for chlorpheniramine 
and dimethindene (first-generation antihistamines) and 
cetirizine, loratadine, and ketotifen (second-generation 
antihistamines).
Statistical analysis
Statistical procedures were done using SPSS software for 
Windows (v 13.0; SPSS Inc, Chicago, IL). Appropriate 
descriptive and analytic methods were used. The Chi-square test 
was used for the statistical analysis of percentages. Differences 
were considered statistically significant at P , 0.05.
Results
We investigated 250 patients (135 boys and 115 girls) of 
mean age 28.3 ± 18.54 months. Using the study checklist, 
84 patients (33.6%) were found to have taken antihistamines 
at onset of fever. The antihistamines administered were 
divided into first-generation and second-generation histamine 
H1 antagonists. No significant difference was observed in 
the gender ratio, age distribution, frequency of family history 
of febrile seizures or epilepsy, and degree of fever between 
the group administered antihistamines and the group not 
administered antihistamines. The clinical characteristics of 
the patients are shown in Table 1 and in Figures 1 and 2.
The 166 children who did not take antihistamines had an 
average seizure duration of 4.5 ± 4.3 minutes. The duration 
was less than 5 minutes in 117 patients (70.5%) and the seizure 
persisted for 15 minutes or longer in 49 patients (29.5%). The 
84 children who took antihistamines had an average seizure 
duration of 9.0 ± 6.1 minutes. Seizure duration was less than 
Table 1 Comparison of characteristics of patients with febrile 
seizures with and without antihistamine administration
Variable Antihistamine 
group A  
n = 84
Nonantihistamine 
group  
n = 166
Gender ratio (boys:girls) 12:10 14:11
Age in months (mean ± SD) 26.8 ± 19.5 29.8 ± 17.4
Family history of febrile  
convulsions, n (%)
43 (51.2%) 80 (48.2%)
Maximum temperature (°C) 39.1°C 39.3°C
Time from fever detection  
to seizure onset, hours  
(mean ± SD)
2.99 ± 0.39 4.27 ± 1.36*
Average seizure duration  
in minutes (mean ± SD)
9.0 ± 6.1* 4.5 ± 4.3
Note: *Statistically significant difference from Group A values are expressed as the 
mean ± SD, numbers, and percentages.
Abbreviation: SD, standard deviation.
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5 minutes in 58 patients (69.0%), and a seizure persisting for 
15 minutes or longer was noted in 26 patients (31%). The 
55 patients who took a first-generation antihistamine had an 
average seizure duration of 9.3 ± 14.2 minutes; the seizure 
duration was less than 5 minutes in 35 patients (63.3%), and 
persisted for 15 minutes or longer in 20 patients (36.7%). 
The 29 children who took a second-generation antihistamine 
had an average seizure duration of 6.0 ± 6.1 minutes, with 
a seizure duration of less than 5 minutes in seven patients 
(79.3%) and for 15 minutes or longer in six patients (20.7%). 
There was a significant difference in seizure duration 
between children who did not take an antihistamine and 
those who took a first-generation antihistamine (P , 0.05). 
The time from fever detection to seizure onset was 
significantly shorter in both the antihistamine groups than 
in the nonantihistamine group (P , 0.05). There was no 
significant difference in the number of cases of simple and 
complex febrile seizures between the groups. There was no 
significant difference in time from fever detection to seizure 
onset or duration of seizure between the group taking a first-
generation antihistamine and that taking a second-generation 
antihistamine (Tables 2 and 3).
Discussion
One of the most interesting findings of this study was the 
observation that antihistamines were so widely used in the 
community for mild intercurrent infections of childhood. 
Although new-generation H1A antagonists with reduced 
adverse effects have already been introduced into clinical use, 
utilization of this group of drugs is limited in pediatric patients. 
Prescription of first-generation H1A antagonists was dominant 
among the 84 H1A (+) cases, ie, first-generation, n = 55, and 
new generation, n = 29. First-generation H1A antagonists are 
still widely used among children in the US as well.11
The main results of this study were that time from fever 
detection to seizure onset was significantly shorter in both 
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Figure 1 Distribution of previous febrile seizure frequency of patients with febrile seizures with and without antihistamine administration.
n = 75 n = 153
n = 9 n = 13
0
20
40
60
80
100
AntihistamineN onantihistamine 
P
e
r
c
e
n
t
a
g
e
 
(
%
)
Simple febrile seizures  Complex febrile seizures  
Figure 2 Distribution of seizure types in patients with febrile seizures with and without antihistamine administration.
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the antihistamine groups compared with the nonantihistamine 
group.2 Seizure duration was significantly longer in the first-
generation antihistamine group than in the nonantihistamine 
group, and there was no significant difference in time from 
fever detection to seizure onset or seizure duration between 
patients given a first-generation antihistamine and those given 
a second-generation antihistamine.3
The results of the current study are supported by those of 
another study10 which investigated the use of drugs, including 
histamine H1 antagonists, in children with febrile seizures. In 
that study, histamine H1 antagonists were taken by 10 (45.5%) 
of 22 patients with febrile seizures and 10 (22.7%) of 
44   control subjects. The use of histamine H1 antagonists was 
significantly higher in patients with febrile seizures than in the 
controls. The histamine H1 antagonists taken by children in 
that study were carbinoxamine and promethazine, which are 
available over-the-counter for the common cold. Miyata et al12 
reported that clinical doses of histamine H1 antagonists have 
the potential to modify seizures adversely in children.
The findings of our study are similar to those of two other 
recent studies13,14 which investigated 14 patients with simple 
febrile seizures and 35 patients with complex febrile seizures, 
and reported that time from fever detection to seizure onset 
was significantly shorter in the antihistamine group than that 
in the nonantihistamine group, and that seizure duration was 
significantly longer in the antihistamine group than that in 
the nonantihistamine group.
The present results demonstrate that administration of 
antihistamines to patients with febrile seizures shortened 
the time from fever detection to seizure onset and prolonged 
the duration of seizures. It is unclear whether interleukin-1β-
mediated systemic inflammatory signals to the central nervous 
system in humans accelerate the turnover of hypothalamic 
neuronal histamine or how it influences seizure susceptibility. 
Considering the anticonvulsant and thermoregulation 
mechanisms controlled by central histaminergic neurons, it 
should be noted that antihistamine administration may induce 
some adverse effects, including neuronal excitability and a 
lower seizure threshold in febrile patients.
Kiviranta et al15 evaluated the possible role of histamine in 
the pathological mechanism of febrile seizures by measuring 
histamine concentrations in the cerebrospinal fluid of febrile 
children with seizures. Febrile children without seizures had 
a significantly higher histamine concentration than children 
with febrile seizures, while nonfebrile children with seizures 
and nonfebrile children without seizures had similar histamine 
concentrations. The increased susceptibility to seizures during 
fever may be related to a lack of increase in the histamine level in 
the cerebrospinal fluid of children with febrile seizures. Central 
histaminergic neuron systems may be involved in inhibiting 
seizures associated with febrile illnesses in childhood.
Interleukin-1β, one of the endogenous pyrogens, 
modulates neural and neuroendocrine activities. This cytokine 
has been shown to induce thermogenesis after infusion into 
Table 2 Time and duration characteristics of patients at onset of febrile seizure
Variable No drugs  
Group A
First-generation   
antihistamine  
Group B
Second-generation   
antihistamine  
Group C
Mean ± SD Mean ± SD Mean ± SD
Time from fever detection to seizure onset (hours) 4.27 ± 1.36 2. 5 ± 0.79* 3.01 ± 037*
Duration of seizure (minutes)   4.5 ± 4.3   9.3 ± 14.2*   6.0 ± 6.1
Note: *Significant difference from Group A, values are expressed as the mean ± SD.
Abbreviation: SD, standard deviation.
Table 3 Distribution of seizure characteristics in patients with and without antihistamine administration at onset of febrile seizure
Variable No drugs   
Group A
First-generation   
antihistamine  
Group B
Second-generation 
antihistamine  
Group C
n (%) n (%) n (%)
Patient distribution 166 (66.4) 55 (22) 29 (11.6)
Duration 5–15 minutes 117 (70.5) 35 (63.3)* 23 (79.3)
From .15 minutes 49 (29.5) 20 (36.7)* 6 (20.7)
Simple febrile seizures 153 (92.2) 49 (89.1) 26 (89.7)
Complex febrile seizures 13 (7.8) 6 (10.9) 3 (10.3)
Note: *Significant difference from Group A, values are expressed as numbers and percentages.
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the central nervous system. Receptors for interleukin-1β 
have been found in high density in the hippocampus, where 
they are located on the soma and dendrites of granule cells.16 
Interleukin-1 receptors at these sites also colocalize with 
N-methyl-D-aspartate receptors that mediate the rapid action 
of glutamate. These receptor areas are crucial sites in the gen-
eration of seizures, because granular neurons play a pivotal 
role in gating the excitatory drive through the hippocampus 
and in modulating the propagation of seizures.17
Although the molecular mechanisms underlying the onset, 
generalization, and recurrence of seizures remain largely 
unknown, functional interactions between interleukin-1β 
and glutamate are of particular relevance for the convulsant 
activity of this cytokine. Therefore, interleukin-1 has been 
suggested to be one of the most important factors causing 
febrile seizures via its dual role as a pyrogen and convulsant 
substance. Hypothalamic neuronal histamine may suppress 
the febrile response induced by interleukin-1β.18
Moreover, an experimental study of central administration 
of interleukin-1β in rats demonstrated that interleukin-1β may 
stimulate synthesis and release of hypothalamic histamine at 
presynaptic terminals by activation of histidine decarboxylase 
(a histamine-synthesizing enzyme) and thus facilitate the 
degradation of extracellular histamine by the activation of 
histamine-N-methyltransferase (a degrading enzyme).18 These 
results indicate that interleukin-1β activates neural histamine 
turnover in the hypothalamus. In conclusion, the results of the 
present study suggest that clinical doses of H1A antagonists 
have the potential to modify the clinical activity of seizures 
in children adversely, and that caution needs to be exercised 
when using these very familiar drugs in this age group.
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